• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾衰竭患者肠道微生物群与肾功能的关联:一项病例对照分析。

Association between intestinal microflora and renal function in patients with chronic renal failure: A case-control analysis.

作者信息

Chen Haixia, Xie Xiaoxiao, Tang Shuming

机构信息

Haixia Chen, Department of Clinical Laboratory, Shenzhen People's, Hospital the Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong Province 518020, China.

Xiaoxiao Xie, Department of Clinical Laboratory, Shenzhen People's, Hospital the Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong Province 518020, China.

出版信息

Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):174-178. doi: 10.12669/pjms.40.1.8194.

DOI:10.12669/pjms.40.1.8194
PMID:38196469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10772418/
Abstract

OBJECTIVE

To identify the association between the changes in intestinal microflora and renal function in patients with chronic renal failure (CRF).

METHODS

This retrospective case-control study included 50 patients with CRF (study group), admitted to the Clinical Laboratory Department of Shenzhen People's Hospital from March 2021 to May 2022, and 50 healthy individuals (control group). The association between the distribution of intestinal microflora and the glomerular filtration rate (GFR), levels of serum creatinine (SCr), blood urea nitrogen (BUN), and serum cystatin C (CysC) were analyzed.

RESULTS

Intestinal microflora of CRF patients had significantly higher levels of Enterococci compared to the control group (p-Value <0.05), while the levels of Bifidobacterium spp. and Escherichia coli were lower in the study group (p-Value <0.05). GFR was lower, and the levels of BUN, SCr, and CysC were higher in the study group compared to the control group (all p-Value <0.05). GFR, BUN, SCr and CysC levels in the study group negatively correlated with the levels of Bifidobacterium spp. and Lactobacillus spp. (r<0, P<0.05), and positively correlated with the abundance of Enterococcus spp. and Escherichia coli (r>0, P<0.05) in the intestinal microflora.

CONCLUSIONS

Changes in intestinal microbiota are associated with a significant decrease in GFR and a marked increase in serum levels of renal function indicators, and alterations in the balance of intestinal microbiota may lead to further aggravation of the renal function damage in patients with CRF.

摘要

目的

确定慢性肾衰竭(CRF)患者肠道微生物群变化与肾功能之间的关联。

方法

这项回顾性病例对照研究纳入了50例CRF患者(研究组),于2021年3月至2022年5月入住深圳市人民医院临床检验科,以及50名健康个体(对照组)。分析肠道微生物群分布与肾小球滤过率(GFR)、血清肌酐(SCr)、血尿素氮(BUN)和血清胱抑素C(CysC)水平之间的关联。

结果

与对照组相比,CRF患者肠道微生物群中的肠球菌水平显著更高(p值<0.05),而研究组中的双歧杆菌属和大肠杆菌水平较低(p值<0.05)。与对照组相比,研究组的GFR较低,BUN、SCr和CysC水平较高(所有p值<0.05)。研究组中的GFR、BUN、SCr和CysC水平与肠道微生物群中双歧杆菌属和乳酸杆菌属的水平呈负相关(r<0,P<0.05),与肠球菌属和大肠杆菌的丰度呈正相关(r>0,P<0.05)。

结论

肠道微生物群的变化与GFR显著降低和肾功能指标血清水平显著升高有关,肠道微生物群平衡的改变可能导致CRF患者肾功能损害进一步加重。

相似文献

1
Association between intestinal microflora and renal function in patients with chronic renal failure: A case-control analysis.慢性肾衰竭患者肠道微生物群与肾功能的关联:一项病例对照分析。
Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):174-178. doi: 10.12669/pjms.40.1.8194.
2
Serum Cystatin, Chemokine, and Gastrin-Releasing Peptide Precursors and Their Clinical Value in Patients with Chronic Renal Failure.血清胱抑素、趋化因子和胃泌素释放肽前体及其在慢性肾衰竭患者中的临床价值。
Biomed Res Int. 2022 Jan 21;2022:1775190. doi: 10.1155/2022/1775190. eCollection 2022.
3
Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.失代偿期肝硬化患者中肌酐和胱抑素公式与铬-乙二胺四乙酸肾小球滤过率的比较
J Gastroenterol Hepatol. 2017 Jan;32(1):191-198. doi: 10.1111/jgh.13446.
4
Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.基于血清胱抑素-C水平评估肾移植患者的肾小球滤过率:与其他肾小球滤过率标志物的比较
Transplant Proc. 2004 Jul-Aug;36(6):1757-9. doi: 10.1016/j.transproceed.2004.06.009.
5
[Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease].[胱抑素C作为晚期慢性肾病患者肾小球滤过率的评估指标]
Nefrologia. 2006;26(4):433-8.
6
Serum cystatin C can be used as a marker of renal function even in patients with intestinal urinary diversion.即使在接受肠道尿路改道的患者中,血清胱抑素C也可作为肾功能的标志物。
Asian J Urol. 2015 Jul;2(3):167-169. doi: 10.1016/j.ajur.2015.07.003. Epub 2015 Jul 15.
7
Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.半胱氨酸蛋白酶抑制剂 C 是一种敏感的标志物,可用于检测类风湿关节炎和继发性淀粉样变性患者慢性肾脏病时肾小球滤过率的降低。
Scand J Rheumatol. 2010;39(1):33-7. doi: 10.3109/03009740903042402.
8
Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.胱抑素C作为依维莫司治疗肾细胞癌患者的预测因素。
Cancer Chemother Pharmacol. 2016 Aug;78(2):295-304. doi: 10.1007/s00280-016-3084-9. Epub 2016 Jun 20.
9
Cystatin C: an improved estimator of glomerular filtration rate?胱抑素C:肾小球滤过率的一种改进评估指标?
Clin Chem. 2002 May;48(5):699-707.
10
Clinical evaluation of serum cystatin C and creatinine in patients with chronic kidney disease: a meta-analysis.慢性肾脏病患者血清胱抑素C和肌酐的临床评估:一项荟萃分析。
J Int Med Res. 2013 Aug;41(4):944-55. doi: 10.1177/0300060513480922. Epub 2013 Jun 12.

引用本文的文献

1
Characteristics of vaginal microbiota in pregnant women with cervical insufficiency and its association with adverse pregnancy outcomes.宫颈机能不全孕妇的阴道微生物群特征及其与不良妊娠结局的关联。
Pak J Med Sci. 2025 May;41(5):1381-1387. doi: 10.12669/pjms.41.5.11966.

本文引用的文献

1
Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes-A Systematic Review.慢性肾脏病中的肠道微生物群:从组成到调节以实现更好的结局——一项系统综述
J Clin Med. 2023 Mar 1;12(5):1948. doi: 10.3390/jcm12051948.
2
Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.肾素-血管紧张素系统抑制在晚期慢性肾脏病中的应用。
N Engl J Med. 2022 Dec 1;387(22):2021-2032. doi: 10.1056/NEJMoa2210639. Epub 2022 Nov 3.
3
Efficacy and Safety of for Treating Chronic Kidney Diseases: A Systematic Review and Meta-Analysis.治疗慢性肾脏病的[具体药物或疗法名称未给出]的疗效与安全性:一项系统评价和Meta分析
Evid Based Complement Alternat Med. 2022 Jun 14;2022:2117433. doi: 10.1155/2022/2117433. eCollection 2022.
4
Identification of colistin resistance and its bactericidal activity against uropathogenic gram negative bacteria from Hayatabad Medical Complex Peshawar.白沙瓦哈亚塔巴德医疗中心尿路致病性革兰氏阴性菌的黏菌素耐药性鉴定及其杀菌活性
Pak J Med Sci. 2022 Mar-Apr;38(4Part-II):981-986. doi: 10.12669/pjms.38.4.5221.
5
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
6
Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules.肠杆菌胶囊口服治疗后伴焦虑和抑郁的肠易激综合征患者肠道菌群的动态变化。
Bioengineered. 2021 Dec;12(2):11885-11897. doi: 10.1080/21655979.2021.1999374.
7
Tianwang Buxin Granules Influence the Intestinal Flora in Perimenopausal Insomnia.天王补心颗粒对围绝经期失眠症患者肠道菌群的影响
Biomed Res Int. 2021 Nov 16;2021:9979511. doi: 10.1155/2021/9979511. eCollection 2021.
8
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes.非奈利酮可降低慢性肾脏病合并 2 型糖尿病患者的新发心房颤动风险。
J Am Coll Cardiol. 2021 Jul 13;78(2):142-152. doi: 10.1016/j.jacc.2021.04.079. Epub 2021 May 17.
9
Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.恩格列净作为附加疗法对因急性失代偿性心力衰竭住院的糖尿病患者的充血和肾功能的影响:一项前瞻性随机对照研究。
Circ Heart Fail. 2021 Mar;14(3):e007048. doi: 10.1161/CIRCHEARTFAILURE.120.007048. Epub 2021 Mar 5.
10
Dapagliflozin in Patients with Chronic Kidney Disease.达格列净治疗慢性肾脏病患者。
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.